Bal Pharma has acquired 100% shareholding, management control and ownership of Golden Drugs, an Udaipur, Rajasthan based private limited Company, which is in the business of manufacturing of API’s/ Bulk Drugs. With this acquisition, Golden Drugs becomes a wholly owned subsidiary of Bal Pharma.
The Board of Directors of the Company at their meeting held on March 22, 2018 has approved the signing of the share purchase agreement (SPA) with the Directors and shareholders of Golden Drugs, with a purchase consideration of Rs 20.66 per equity shares of Rs 10 each of the said company.
Bal Pharma is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1659.55 |
| Dr. Reddys Lab | 1218.70 |
| Cipla | 1231.35 |
| Zydus Lifesciences | 932.55 |
| Lupin | 2315.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: